Mairéad Farrell
Ceist:711. Deputy Mairéad Farrell asked the Minister for Health the reason the HSE claims to be saving €4 million per year using biosimilar teriparatide, when the cost of managing fractures is estimated to be increasing by approximately €100 million per year. [36460/24]
Amharc ar fhreagra